首页> 外文期刊>Nature >Structural basis of CXC chemokine receptor 2 activation and signalling
【24h】

Structural basis of CXC chemokine receptor 2 activation and signalling

机译:CXC趋化因子受体2激活和信号的结构基础

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chemokines and their receptors mediate cell migration, which influences multiple fundamental biological processes and disease conditions such as inflammation and cancer(1). Although ample effort has been invested into the structural investigation of the chemokine receptors and receptor-chemokine recognition(2-4), less is known about endogenous chemokine-induced receptor activation and G-protein coupling. Here we present the cryo-electron microscopy structures of interleukin-8 (IL-8, also known as CXCL8)-activated human CXC chemokine receptor 2 (CXCR2) in complex with G(i) protein, along with a crystal structure of CXCR2 bound to a designed allosteric antagonist. Our results reveal a unique shallow mode of binding between CXCL8 and CXCR2, and also show the interactions between CXCR2 and G(i) protein. Further structural analysis of the inactive and active states of CXCR2 reveals a distinct activation process and the competitive small-molecule antagonism of chemokine receptors. In addition, our results provide insights into how a G-protein-coupled receptor is activated by an endogenous protein molecule, which will assist in the rational development of therapeutics that target the chemokine system for better pharmacological profiles.Structures of the G(i)-coupled CXC chemokine receptor 2 (CXCR2) in complex with CXCL8 and in complex with an allosteric antagonist provide insight into the ligand binding and activation of CXCR2 and its mode of G-protein coupling.
机译:趋化因子及其受体介导细胞迁移,这影响了多种基本的生物过程和疾病病症,如炎症和癌症(1)。尽管已经投入了趋化因子受体和受体 - 趋化因子识别(2-4)的结构研究,但较少是关于内源性趋化因子诱导的受体活化和G-蛋白偶联的含量较低的。在这里,我们将白细胞介素-8(IL-8,也称为CXCL8)的冷冻电子显微镜结构呈与G(I)蛋白的复合物,以及CXCR2结合的晶体结构到设计的颠覆拮抗剂。我们的结果揭示了CXCL8和CXCR2之间的独特浅模式,并显示了CXCR2和G(I)蛋白质之间的相互作用。 CXCR2的无活性和活性状态的进一步结构分析显示出明显的激活过程和趋化因子受体的竞争性小分子拮抗作用。此外,我们的结果提供了对内源性蛋白质分子如何激活G蛋白偶联受体的见解,这将有助于靶向趋化因素的治疗剂的合理发育,以获得更好的药理学谱。G(i)的结构结构 - 用CxCl8和络合物中的CXC趋化因子受体2(CXCR2)与CXCL8和络合物中的颠致拮抗剂提供了对CXCR2的配体结合和激活的洞察力及其G蛋白偶联的模式。

著录项

  • 来源
    《Nature》 |2020年第7823期|135-140|共6页
  • 作者单位

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai Peoples R China|Univ Chinese Acad Sci Beijing Peoples R China|Chinese Acad Sci Ctr Excellence Mol Cell Sci Shanghai Inst Biochem & Cell Biol Shanghai Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China;

    Chinese Acad Sci Res Ctr Comp Aided Drug Discovery Shenzhen Inst Adv Technol Shenzhen Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai Peoples R China|Univ Chinese Acad Sci Beijing Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China;

    Chinese Acad Sci Res Ctr Comp Aided Drug Discovery Shenzhen Inst Adv Technol Shenzhen Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China;

    ShanghaiTech Univ iHuman Inst Shanghai Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号